HUM vs HYPR · P/E 39, rev $117.76B vs rev $12.9M
Humana Inc (HUM) versus Hyperfine Inc (HYPR) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Hyperfine Inc (HYPR) is a medical devices company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported HYPR revenue for 2024-12-31 was $12.9M. Net income was -$40.7M. Revenue was up 16.8% from 2023-12-31 to 2024-12-31. HYPR currently screens at market cap $141.5M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. HYPR currently screens at market cap $141.5M.
Not investment advice. Open the HUM and HYPR stock pages for the full models.
Not investment advice.